Buprenorphine Transdermal System

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
012320102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVES To evaluate utilization patterns in patients initiating buprenorphine transdermal system (BTDS), CIII, and estimate… (More)
Is this relevant?
2015
2015
OBJECTIVES Persistence, the duration a patient remains on therapy, in chronic, symptomatic conditions plays an important role in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
OBJECTIVE This study examines the efficacy of the buprenorphine transdermal system (BTDS) for reducing the interference of pain… (More)
Is this relevant?
2013
2013
CONTEXT Transdermal formulations of buprenorphine offer controlled delivery of buprenorphine for sustained analgesic efficacy… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2013
2013
OBJECTIVE To characterize the profile of application site reactions (ASRs) for patients treated with the buprenorphine… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2012
2012
OBJECTIVE The objective of this study was to evaluate continued pain control and tolerability of converting patients from Vicodin… (More)
Is this relevant?
2011
2011
UNLABELLED In this enriched design study, 1,160 opioid-experienced patients with chronic, moderate to severe low back pain… (More)
Is this relevant?
2011
2011
CONTEXT This article presents the results of a pivotal Phase 3 study that assesses a new treatment for the management of chronic… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2010
2010
BACKGROUND This multicenter, parallel-group, 35-day study in adults with osteoarthritis (OA) pain evaluated the analgesic… (More)
Is this relevant?
Review
2010
Review
2010
OBJECTIVE The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine… (More)
Is this relevant?